Ghassan K Abou-Alfa

Ghassan K Abou-Alfa

UNVERIFIED PROFILE

Are you Ghassan K Abou-Alfa?   Register this Author

Register author
Ghassan K Abou-Alfa

Ghassan K Abou-Alfa

Publications by authors named "Ghassan K Abou-Alfa"

Are you Ghassan K Abou-Alfa?   Register this Author

100Publications

2823Reads

39Profile Views

Immune checkpoint inhibitors for hepatocellular carcinoma.

Cancer 2019 Oct 10;125(19):3312-3319. Epub 2019 Jul 10.

Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32076DOI Listing
October 2019

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.

Lancet Gastroenterol Hepatol 2019 Sep 9;4(9):711-720. Epub 2019 Jul 9.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30189-XDOI Listing
September 2019

Evaluation and management of incidental gallbladder cancer.

Chin Clin Oncol 2019 Aug 5;8(4):37. Epub 2019 Aug 5.

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.07.01DOI Listing
August 2019

Biliary tract cancer prognostic and predictive genomics.

Chin Clin Oncol 2019 Aug 29;8(4):42. Epub 2019 Jul 29.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.07.06DOI Listing
August 2019

Gallbladder cancer, a forgotten global cancer problem.

Chin Clin Oncol 2019 Aug 5;8(4):30. Epub 2019 Aug 5.

Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.07.11DOI Listing
August 2019

Systemic therapy for gallbladder cancer.

Chin Clin Oncol 2019 08;8(4):44

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.08.14DOI Listing
August 2019

Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?

Dig Dis Sci 2019 04;64(4):918-927

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05517-6DOI Listing
April 2019

Ramucirumab and the controversial role of α-fetoprotein in hepatocellular carcinoma.

Lancet Oncol 2019 Feb 18;20(2):177-179. Epub 2019 Jan 18.

Memorial Sloan Kettering Cancer Center, 300 East 66th St, New York, NY 10065, USA; Weill Medical College at Cornell University, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30009-9DOI Listing
February 2019

Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.

Hum Pathol 2019 Jan 17;83:1-6. Epub 2018 Aug 17.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365190PMC
January 2019

Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.

Curr Treat Options Oncol 2019 Jan 11;20(2). Epub 2019 Jan 11.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0601-1
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0601-1DOI Listing
January 2019

The Use of Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.

Gastroenterol Hepatol (N Y) 2019 Jan;15(1):48-50

Attending Physician Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College at Cornell University New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423691PMC
January 2019

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach.

J Hepatocell Carcinoma 2019 31;6:41-48. Epub 2019 Jan 31.

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JHC.S194764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362920PMC
January 2019

Cabozantinib in Hepatocellular Carcinoma.

N Engl J Med 2018 10;379(14):1384-1385

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1810178DOI Listing
October 2018

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

N Engl J Med 2018 Jul;379(1):54-63

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (G.K.A.-A.); Royal Free Hospital and University College London, London (T.M.); National Taiwan University Hospital, Taipei (A.-L.C.), and the Department of Medical Oncology, Liouying Chi Mei Hospital, Tainan (Y.C.) - both in Taiwan; USC Norris Comprehensive Cancer Center, Los Angeles (A.B.E.-K.), UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (A.P.V., R.K.K.), and Exelixis, Alameda (C.H., A.E.B.-H., G.S.) - all in California; Humanitas Cancer Center, Humanitas Clinical and Research Center, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano (L.R., T.P.), the Department of Medical and Surgical Sciences, University of Bologna, Bologna (L.B.), and Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padua (V.Z.) - all in Italy; Asan Medical Center, University of Ulsan College of Medicine, Seoul (B.-Y.R., M.-H.R.), and the National Cancer Center, Goyang (J.-W.P.) - both in South Korea; Trakya University School of Medicine, Edirne, Turkey (I.C.); Groupement Hospitalier Nord, Lyon (P.M.), and Hôpital Haut-Lévêque, Centre Hospitalier Universitaire Bordeaux, Bordeaux (J.-F.B.) - both in France; the Department of Medical Oncology, Academic Medical Center, Amsterdam (H.-J.K.); and the Chinese University of Hong Kong, State Key Laboratory in Oncology in South China, Hong Kong (S.L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1717002DOI Listing
July 2018

Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?

Clin Colorectal Cancer 2018 06 7;17(2):e315-e321. Epub 2018 Feb 7.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2018.01.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759921PMC
June 2018

Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.

Semin Oncol 2018 06 16;45(3):116-123. Epub 2018 Mar 16.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Medical College at Cornell University, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00937754173012
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2018.03.002DOI Listing
June 2018

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

J Clin Oncol 2018 01 28;36(3):276-282. Epub 2017 Nov 28.

Milind Javle and Rachna T. Shroff, The University of Texas MD Anderson Cancer Center, Houston, TX; Maeve Lowery and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Karl Heinz Weiss and Christoph Springfeld, Universitäts Klinikum Heidelberg, Heidelberg, Germany; Mitesh J. Borad, Ramesh K. Ramanathan, and Tanios Bekaii-Saab, Mayo Clinic, Phoenix, AZ; Lipika Goyal and Andrew X. Zhu, Massachusetts General Hospital Cancer Center, Boston, MA; Saeed Sadeghi and Richard S. Finn, David Geffen School of Medicine at UCLA; Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles; Robin Kate Kelley, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Teresa Macarulla, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ivan Borbath, Cliniques Universitaires Saint-Luc, Brussels; Eric Van Cutsem, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium; Su Pin Choo, National Cancer Centre of Singapore, Singapore; Do-Youn Oh, Seoul National University, Seoul, South Korea; Philip A. Philip, Karmanos Cancer Institute, Detroit, MI; Li-Tzong Chen, National Institute of Cancer Research and National Cheng Kung University Hospital, Tainan; Kun-Huei Yeh, National Taiwan University Hospital Cancer Center, and Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan; Thanyanan Reungwetwattana, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Kristen Ciombor, The Ohio State University Wexner Medical Center, Columbus, OH; and Anuradha Patel, Suman Sen, Dale Porter, and Randi Isaacs, Novartis Pharmaceuticals Corporation, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075847PMC
January 2018

Treatment options after sorafenib failure in patients with hepatocellular carcinoma.

Clin Mol Hepatol 2017 12 20;23(4):273-279. Epub 2017 Nov 20.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2017.0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760005PMC
December 2017

Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy.

J Gastrointest Oncol 2017 Oct;8(5):E65-E72

Department of Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2017.06.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674258PMC
October 2017

The role (if any) of chemotherapy in hepatocellular carcinoma.

Lancet Gastroenterol Hepatol 2017 06 6;2(6):387-389. Epub 2017 Apr 6.

Department of Medicine, Weill Cornell Medical Colleage, New York, NT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(17)30104-8DOI Listing
June 2017

Proportion of cancer in a Middle eastern country attributable to established risk factors.

BMC Cancer 2017 05 18;17(1):337. Epub 2017 May 18.

Department of Hematology-Oncology, American University of Beirut Medical Center, P.O Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3304-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437575PMC
May 2017

Hepatocellular adenoma among adult survivors of childhood and young adult cancer.

Pediatr Blood Cancer 2017 04 26;64(4). Epub 2016 Oct 26.

Adult Long Term Follow-Up Program, Memorial Sloan Kettering, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477223PMC
April 2017

Specific immunotherapy in hepatocellular cancer: A systematic review.

J Gastroenterol Hepatol 2017 Feb;32(2):339-351

Border of Immune Tolerance Education and Research Network (BITERN), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.13449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377153PMC
February 2017

Hepatocellular carcinoma in patients with HIV.

Curr Opin HIV AIDS 2017 01;12(1):20-25

aMemorial Sloan Kettering Cancer Center bWeill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0000000000000335DOI Listing
January 2017

Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.

J Clin Oncol 2017 01 23;35(2):258-259. Epub 2016 Oct 23.

Karen T. Brown and Richard Do, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Mithat Gönen, Memorial Sloan Kettering Cancer Center, New York, NY; Anne M. Covey, George I. Getrajdman, and Constantinos T. Sofocleous, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; William R. Jarnagin, Michael I. D'Angelica, and Peter J. Allen, Memorial Sloan Kettering Cancer Center, Columbia University College of Physicians and Surgeons, and Weill Cornell Medical College, New York, NY; Joseph P. Erinjeri and Lynn A. Brody, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Gerald P. O'Neill, Kristian Johnson, Alessandra R. Garcia, and Christopher M. Beattie, Memorial Sloan Kettering Cancer Center, New York, NY; Binsheng Zhao, Columbia University College of Physicians and Surgeons, New York, NY; Stephen B. Solomon, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lawrence H. Schwartz, Columbia University College of Physicians and Surgeons, New York, NY; Ronald P. DeMatteo, Memorial Sloan Kettering Cancer Center, Columbia University College of Physicians and Surgeons, and Weill Cornell Medical College, New York, NY; and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7961DOI Listing
January 2017

Pancreatic neuroendocrine tumor with aneurysms of the gastroduodenal artery: a case report.

Clin Imaging 2016 Mar-Apr;40(2):228-31. Epub 2015 Nov 11.

American University of Beirut Medical Center, Beirut, Lebanon. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2015.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989911PMC
November 2016

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.

Liver Cancer 2016 Nov 29;6(1):16-26. Epub 2016 Nov 29.

Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159738PMC
November 2016

Preface: special issue on biliary cancer.

Chin Clin Oncol 2016 Oct;5(5):E2

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.10.11DOI Listing
October 2016

Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency.

Chin Clin Oncol 2016 Oct;5(5):62

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.10.04DOI Listing
October 2016

Systemic therapy for biliary cancers.

Chin Clin Oncol 2016 Oct;5(5):65

Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.10.08DOI Listing
October 2016

Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Chin Clin Oncol 2016 Oct;5(5):66

Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.10.02DOI Listing
October 2016

Advanced Hepatocellular Cancer: the Current State of Future Research.

Curr Treat Options Oncol 2016 08;17(8):43

Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-016-0415-3DOI Listing
August 2016

A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.

Ann Surg 2016 Jun;263(6):1112-25

*Department of Surgery, Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA†Department of Surgery, Division of Surgical Oncology, University of Nebraska Medical Center, Omaha, NE‡Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE§Department of Radiology, University of Nebraska Medical Center, Omaha¶Department of Radiology, Surgery and Oncology, Johns Hopkins School of Medicine, Baltimore, MD||Department of Surgery, Division of General Surgery, Abdominal Transplantation Section, Washington University School of Medicine, St. Louis, MO**Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001556DOI Listing
June 2016

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

J Clin Oncol 2016 06 1;34(17):2046-53. Epub 2016 Feb 1.

Karen T. Brown, Richard K. Do, Mithat Gonen, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, Michael I. D'Angelica, Peter J. Allen, Joseph P. Erinjeri, Lynn A. Brody, Gerald P. O'Neill, Kristian N. Johnson, Alessandra R. Garcia, Christopher Beattie, Stephen B. Solomon, Ronald DeMatteo, and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center; Binsheng Zhao and Lawrence H. Schwartz, Columbia University College of Physicians and Surgeons; and Karen T. Brown, Richard K. Do, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, Michael I. D'Angelica, Peter J. Allen, Joseph P. Erinjeri, Lynn A. Brody, Stephen B. Solomon, Ronald DeMatteo, and Ghassan K. Abou-Alfa, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.0821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966514PMC
June 2016

Acute myeloid leukemia masquerading as hepatocellular carcinoma.

J Gastrointest Oncol 2016 Jun;7(3):E31-5

1 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Medicine, Weill Cornell Medical College, New York, NY, USA ; 3 Departments of Pathology and Laboratory Medicine, 4 Department of Radiology, 5 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 6 Department of Surgery, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2015.12.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880775PMC
June 2016

Hepatocellular carcinoma tumor board: making sense of the technologies.

Am Soc Clin Oncol Educ Book 2015 :e213-20

From the Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY; The University of Texas Southwestern, Dallas, TX; The University of Chicago, Chicago, IL; and Pisa University Hospital and School of Medicine, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e213DOI Listing
February 2016

Immunotherapy in hepatocellular carcinoma: Primed to make a difference?

Cancer 2016 Feb 5;122(3):367-77. Epub 2015 Nov 5.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29769DOI Listing
February 2016

The use of genetic alterations in the development of liver cancer drugs.

Clin Adv Hematol Oncol 2015 Dec;13(12):826-8

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
December 2015

The Use of Genetic Alterations in the Development of Liver Cancer Drugs.

Gastroenterol Hepatol (N Y) 2015 Dec;11(12):833-5

Associate Professor Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center Weill Cornell Medical College New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849513PMC
December 2015

"This is not me": patient, family, cultural and clinician considerations in cases of severe cancer-related debility.

J Gastrointest Oncol 2015 Oct;6(5):589-93

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Weill Cornell Medical College, New York, NY, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 National Guard Hospital at King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570910PMC
October 2015

Liver resection for metastatic colorectal leiomyosarcoma: a single center experience.

J Gastrointest Oncol 2015 Oct;6(5):E70-6

1 Liver Transplantation and Hepatopancreaticobiliary Surgery, Department of General Surgery, 2 Department of Surgery, 3 Division of Hematology and Oncology, Department of Internal Medicine, 4 Department of Pathology, American University of Beirut Medical Center, Beirut, Lebanon ; 5 Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 6 Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://www.thejgo.org/article/view/4396/4951
Publisher Site
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570914PMC
October 2015

Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread.

J Vasc Interv Radiol 2015 Aug 30;26(8):1112-21. Epub 2015 May 30.

Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2015.04.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535717PMC
August 2015

Consensus conference on intrahepatic cholangiocarcinoma.

HPB (Oxford) 2015 Aug;17(8):661-3

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hpb.12438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527849PMC
August 2015

Liver-directed conversion therapy in metastatic colon cancer.

J Gastrointest Oncol 2015 Jun;6(3):322-8

1 Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA ; 2 Weill Cornell Medical College, New York, NY, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 National Guard Hospital at King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397241PMC
June 2015

Treating advanced hepatocellular carcinoma: How to get out of first gear.

Cancer 2014 Oct 4;120(20):3122-30. Epub 2014 Jun 4.

Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28850DOI Listing
October 2014

Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?

Hepatobiliary Surg Nutr 2014 Aug;3(4):168-71

Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3881.2014.07.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141298PMC
August 2014

Sorafenib use in hepatocellular carcinoma: more questions than answers.

Hepatology 2014 Jul;60(1):15-8

Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Internal Medicine, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27044DOI Listing
July 2014

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.

Ann Surg 2014 Jul;260(1):142-8

*Gastrointestinal Oncology Service †Department of Medicine ‡Hepatopancreaticobiliary Surgery Service §Gastroenterology and Nutrition Service Departments of ¶Epidemiology and Biostatistics ‖Pathology **Radiology ††Surgery; and ‡‡Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520299PMC
July 2014

From the liver to the foot: a case of systemic embolism and acrometastasis in hepatocellular carcinoma.

Gastrointest Cancer Res 2014 May;7(3-4):103-7

Memorial Sloan-Kettering Cancer Center New York, NY ; Weill Cornell Medical College New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171976PMC
May 2014

Expert perspectives on evidence-based treatment planning for patients with hepatocellular carcinoma.

Cancer Control 2014 Apr;21(2 Suppl):5-16

University of Texas Southwestern Medical Center, Dallas, TX 75390.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073274814021002s02DOI Listing
April 2014

A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

Gastrointest Cancer Res 2014 Mar;7(2):55-8

Memorial Sloan-Kettering Cancer Center New York, NY ; Weill Cornell Medical College New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007677PMC
March 2014

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.

J Hepatol 2014 Feb 14;60(2):319-24. Epub 2013 Sep 14.

Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Department of Internal Medicine, Weill Medical College at Cornell University, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901953PMC
February 2014

A woman with metastatic pancreatic neuroendocrine tumor.

Gastrointest Cancer Res 2014 Jan;7(1):27-32

Memorial Sloan-Kettering Cancer Center New York, NY ; Weill Medical College at Cornell University New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924762PMC
January 2014

The role of tyrosine kinase inhibitors in hepatocellular carcinoma.

Clin Adv Hematol Oncol 2014 Jan;12(1):36-41

Weill Medical College, Cornell University, New York, New York.

View Article

Download full-text PDF

Source
January 2014

Hepatocellular carcinoma: what is happening everywhere?

Chin Clin Oncol 2013 Dec;2(4):31

Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.12.01DOI Listing
December 2013

Systemic therapy for hepatocellular carcinoma.

Chin Clin Oncol 2013 Dec;2(4):37

Weill Medical College at Cornell University, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.07.06DOI Listing
December 2013

Status of hepatocellular carcinoma in Gulf region.

Chin Clin Oncol 2013 Dec;2(4):42

National Center for Cancer Care and Research, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.11.02DOI Listing
December 2013

Risk factors for developing hepatocellular carcinoma in Egypt.

Chin Clin Oncol 2013 Dec;2(4):43

Endemic Medicine Department, Faculty of Medicine, Cairo University, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.11.07DOI Listing
December 2013

An update on clinical trials in the treatment of advanced hepatocellular carcinoma.

J Clin Gastroenterol 2013 Jul;47 Suppl:S16-9

Memorial Sloan-Kettering Cancer Center, Cornell University, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jcge/2013/07001/An_Update_on_Cl
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MCG.0b013e31827d77a2DOI Listing
July 2013

The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?

Lancet Oncol 2013 Jun;14(7):e283-8

Section of Gastrointestinal Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470204513
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451370161
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70161-XDOI Listing
June 2013

Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?

World J Surg Oncol 2013 Jun 6;11:131. Epub 2013 Jun 6.

Liver Transplantation and Hepatopancreaticobiliary Surgery, Department of General Surgery, American University of Beirut, Cairo Street, Beirut 1107 2020, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-11-131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693928PMC
June 2013